Pseudomonas tolaasii is a bacterium endemic to the compost beds where common mushroom (Agaricus bisporus) is cultivated. Under some environmental conditions still not well-determined, but influenced by temperature and relative humidity, the bacterium can become pathogenic and provoke the brown blotch disease. This review describes the interaction between P. tolaasii and A. bisporus that results in the appearance of brown spots on the mushroom caps, typical symptoms of the disease. Firstly, P. tolaasii is studied, the changes in pathogenicity are explained, the compounds that provoke the damage are enumerated as well as various experimental methods to identify the pathogenic form of the bacteria. Secondly, mechanisms involved in the formation of the brown colour on the A. bisporus caps upon infection are briefly mentioned, taking into account the enzymes that catalyse the reaction, their mechanism, substrates and reaction products. Afterwards, a detailed description of the infection process is presented step by step, starting by the chemotactical attraction, fixation, secretion of the toxins, membrane breakdown, effect of the toxin on mushroom polyphenol oxidases and on the discolouration reaction. A possible mechanism of infection is hypothesised at the molecular level. Finally, the strategies tested until now to control the disease are discussed. ß
Introduction
The cultivated button mushroom, or champignon (Agaricus bisporus), is one of the more extensively cultivated mushrooms in the world. Its production exceeds 1.8U10 6 tonnes per year, 8^9U10 5 of these are cultivated in Europe (ca. 2 billion Euros) [1] . The Netherlands and France are the countries with the highest production of mushrooms (2.4 and 1.6U10 5 tonnes, respectively), followed by the UK, with an annual production of ca. 10 5 tonnes [2] . General consumer preferences require a high quality A. bisporus to be completely white, with a closed veil, short stipe and no visible gills [3] . It should also have a tender but not soft texture and the characteristic mushroom odour [4] .
The mushroom quality declines rapidly in the bed due to a maturation or senescence process which is in fact the natural development of fruit bodies for the production of spores [5] . But the most problematic reducer of quality is the microbial colonisation of mushroom caps. Pre-harvest bacterial populations and factors that in£uence their size play an important role in the post-harvest quality of mushrooms. Bacterial counts are reported between 1.7^2.9U10 8 colony forming units (cfu) g 31 from the casing layer through six £ushes of a crop cycle. Aseptically harvested mushrooms from the ¢rst ¢ve £ushes of this crop yielded approximately 10 7 cfu g 31 [6] . According to the growers,`the worst disease' because of the large economic losses that can occur is the brown blotch or bacterial blotch disease. When the disease is detected in a farm, it is very di¤cult to eradicate. It can easily became an epidemic that is rapidly spread into the other mushroom houses, causing a general loss of crop yield and a decrease in quality. Although bacterial spoilage does not cause any health problems, it can result in a loss in consumer appeal in the market place.
The incidence of the disease di¡ers from one country to another and from year to year. In France, where most cultivations are carried out in caves, it was found periodically during summer or autumn, the incidence could vary from 8 to 15% of the crop weight, sometimes however exceeding 50% [7] . In The Netherlands and the UK, 10^15% of the production is a¡ected every year [2, 8] . In Italy, crops were reduced until 40% in dramatic years, the infection usually being worst in spring or autumn [9] .
The disease has been detected and described all over the world since many years and it a¡ects not only the button mushroom market (in the USA [10] , Australia [11] , Israel [12] and Turkey [13] ) but also the market of so-called`exotic' mushrooms (Pleurotus, Lentinula, Flammulina, etc.) important in eastern countries (Japan [14] , Korea [15] , China [16] and India [17] ).
Brown blotch is a bacterial disease caused by Pseudomonas tolaasii [18] . Colonisation of mushroom caps by the bacterium results in development of unappealing brown or cream lesions on pileus and stipe. These lesions are slightly concave spots, round or spreading in many directions [7] . The spots may be small (1^4 mm diameter) and pale brown. When the damage is more intense, the spots are darker and sunken. Browning a¡ects only the external layers of the cap tissues and is restricted to 2^3 mm below the surface of the cap. Lesions may coalesce to cover the entire mushroom surface. In other situations, only small black or brown punctuations are observed [2] ( Fig. 1) .
When a farm is a¡ected, the ¢rst indication of the infection is a fairly late onset of fruitbody formation and reduction of the crop, where maturing mushrooms (all developmental stages) develop super¢cial brown lesions. Blotch can occur as a few lesions on only a few mushrooms or as a severe incidence where all the mushrooms on a bed are severely a¡ected. It can be noticed since the early ¢rst £ush until the latest [19] .
Some mushrooms seem to be healthy after picking but may develop symptoms during post-harvest storage. This may even occur when they are stored at low temperatures, because the bacterium possesses the ability of growing at low temperatures [20] . In harvested mushrooms, a faster rate of deterioration was observed, particularly when stored in relatively high humidity conditions such as in ¢lm-overwrapped packages [21] .
This review presents a detailed outlook of the state of the art with respect to biochemical and physiological aspects of bacterial blotch disease. In the ¢rst part, recent studies about P. tolaasii in relation to the infection process are described. The second part brie£y summarises the compounds directly related to the browning mechanism of the mushroom. The third part deals with the events during the infection process, the attack of the bacterium, the defence of the mushroom and the consequences of the interaction from a molecular point of view. In a fourth part, current strategies to control the disease are reviewed.
2. The causal agent of the disease: P. tolaasii P. tolaasii was o¤cially positioned into the taxonomic group of £uorescent Pseudomonas biotype II. Many other recent studies disagree with this classi- ¢cation and claim that it should be placed as separate species or into another group. However, its position in the systematic classi¢cation is still unclear because of the high heterogeneity of the group [2, 22] .
Morphological characteristics
P. tolaasii colonies were reported to present two di¡erent appearances when cultivated on King's B medium [23] or Pseudomonas agar F [24] . The wildtype or smooth form showed small, semi-mucoid [25] , opaque and non-£uorescent colonies and was pathogenic for mushrooms. The variant type or rough form presented large, non-mucoid, translucent and £uorescent colonies, which were not pathogenic [16] .
This second rough variant appeared spontaneously from sectors in wild-type colonies after a few days of incubation [26] . When smooth forms change to rough, the alteration in colony morphology is correlated with changes in biochemical characteristics. Some possible hypotheses have been suggested which might explain the instability of the forms such as spontaneous mutation, phase variation or loss of a plasmid, common mechanisms for other bacteria [16] . Plasmid loss was not responsible for the switch [27] , because reversion from the non-pathogenic to the pathogenic form was detected on diseased mushroom caps [28] . Apparently, the phenotypic variation in P. tolaasii occurs when cells are present at a high density. Depletion of nutrients and the formation of secondary metabolites seem to a¡ect the expression of a speci¢c gene, designated pheN. The pheN locus is a 3-kb region (3.4 kb according to Han et al. [29] ) in the genome of the smooth form of P. tolaasii that was found to be necessary to maintain the smooth pathogenic phenotype [26] . The loss of the pheN gene or its function resulted in conversion of the smooth form to the phenotypic rough form.
The pheN locus contained a 2727-bp open reading frame encoding a 83-kDa protein (99 kDa according to Han et al. [29] ). This protein shows similarities (in sequence and in the presence of two domains) to the two-component regulatory proteins occurring in many Gram-negative bacteria which coordinately regulate the expression of multiple genes in response to environmental conditions [30] . The protein encoded by the pheN gene contains two hydrophobic domains anchoring the protein in the cytoplasmic membrane (containing the amino-terminal region) and two others oriented towards the cytoplasm, the transmitter and regulator domains (carboxy-terminal region). The amino-terminal extra-cytoplasmic domain of the pheN protein senses the environment, transfers signals to its transmitter domain and this domain in£uences the carboxy-terminus response regulator module. The response regulator domain directly, or using intermediate compounds, controls the expression of further genes. Therefore, pheN could activate the expression of the genes involved in tolaasin synthesis, protease production and mucus production but represses other genes controlling siderophore production, mobility, chemotaxis, etc.
When depletion of nutrients occurs, the transcription of pheN product is suppressed as a result of DNA rearrangements in the pheN locus. Phenotypic switch of the smooth form into the rough form arises because of a 661-bp duplication within the gene. Duplication occurs at the starting signal for transcription inducing the synthesis of two proteins, a 27-kDa polypeptide and the pheN open reading frame protein with 204 amino acids less than the wild-type protein (77 kDa instead of 99 kDa). This 22-kDa fragment is lacking from the N-terminus of pheN, so the loss of this domain may result in loss of the pheN function since the N-terminal domain is the environmental sensor. The mechanism of the DNA duplication event in P. tolaasii is still unknown [29] .
Han et al. [31] mentioned another locus called pheR implicated in regulation of the phenotypic variation of the bacterium. The role of this locus is currently being investigated.
Saprophycity and pathogenicity
The ability to switch into a rough or smooth pathotype allows the bacterium to colonise multiple environmental substrates. Pseudomonas is a genus highly capable of surviving in nutrient-poor media by adjustment of several enzymatic pathways which gives them advantages over possible competitors. For this reason, P. tolaasii can live as a saprophytic or as a pathogenic microorganism.
As a pathogen, P. tolaasii is not host speci¢c, as it can infect almost all species of mushrooms and also various plants. The economically most important edible mushrooms, Lentinula edodes [32] , Pleurotus ostreatus [33] , P. eryngii [34] , Flammulina velutipes [35] , Agaricus bisporus, A. bitorquis and other Agaricales [36] are usual hosts. P. tolaasii is also described as pathogenic for some plants such as cauli£owers [37] , potato tuber slices where it induces blackening [38] , Nicotiana tabacum, other Solanum sp. [39] and strawberries [40] .
P. tolaasii has also been described as a saprophytic bacterium from pears [41] and beans (Phaseolus vulgaris). Colonisation of bean roots by some Pseudomonas species such as P. tolaasii, Pseudomonas putida and Pseudomonas aureofaciens results in a selective induction of the synthesis of certain acid-soluble proteins involved in defence strategies [42] . It also inhibits growth of plant pathogenic bacteria [38] .
2.3.
Agents which facilitate the access to the nutrients
Proteinases and lipases
Most members of the Pseudomonas genus produce very active extracellular enzymes, in particular proteinases and lipases. Such proteins are often directly involved in crop spoilage. The most proteolytic species produce only one proteinase [43] . P. tolaasii was found to produce an extracellular monomeric metallo-proteinase of 45^50 kDa, very similar in most respects to those secreted by other Pseudomonas species [44] . The proteinase was produced mainly during the exponential phase of growth increasing slightly during the stationary phase. The e¡ect of this proteinase in mushroom infection is still unknown but it may facilitate the damage caused in the mushroom [45] .
Other enzymes possibly involved in the infection process are lipases. Lipases are shown to facilitate bacterial infections by disrupting host membranes. P. tolaasii, as many other pathogenic Pseudomonas, produces an extracellular heat-stable monomeric metallo-lipase of 670 kDa [46] . The role of this lipase during the infection of mushroom requests also further study.
Siderophores
Siderophores, secreted by P. tolaasii, may help in the spread of the epidemic and inhibition of the hyphal growth of A. bisporus mycelium. These compounds are small molecules which transport iron into the cells by a high-a¤nity transport system. The very strong chelating properties of these siderophores exert an antagonist action against other microorganisms which are no longer able to acquire essential supplies of iron, resulting in growth inhibition.
Pyoverdines are the most common siderophores in the Pseudomonas genus. Pyoverdine-mediated iron transport appeared to be strictly strain speci¢c [47] . P. tolaasii produces three siderophores that are chromopeptides: pyoverdine Pt, Pt A and Pt B [48] . The peptidic part of pyoverdine type siderophores is synthesised by peptide synthetases located in the cytoplasm called`iron-repressed cytoplasmic proteins' (IRCPs). The IRCPs are strain dependent, presenting molecular mass values ranging from 180 to 600 kDa [49] .
Toxins
Tolaasin is an extracellular toxin that has extensively been studied and characterised. It is produced only by the pathogenic form of P. tolaasii. When applied directly on mushrooms, it can reproduce the symptoms of the disease. It might therefore be a compound highly involved in the damage [50^52].
Production of tolaasin
Results concerning the production of tolaasin during bacterial cultivation di¡ered from one author to another. According to Nair and Fahy [50] , the toxin production started at the early stage of exponential growth (corresponding with the increase in the number of cells) and ceased during late exponential growth. The toxicity index did not show any further increase beyond the exponential phase into the stationary phase of bacterial growth.
A few years later, Rainey et al. [39] found a di¡er-ent result. An increase in the amount of tolaasin was noticed during the stationary phase. These authors showed an exponential toxin production during cell growth starting at the mid-exponential phase and continuing throughout the stationary phase. They also observed a sudden decrease in the number of viable cells coinciding reproducibly with the onset of tolaasin production. Later, Baral et al. [45] did not observe such a decrease.
Other authors claimed that the highest rate of tox-in production commenced after the culture reached the stationary growth phase [53] .
Puri¢cation of tolaasin
The toxin was puri¢ed for the ¢rst time by Nutkins et al. [54] . It consisted of two principal components with molecular masses of 1985 and 1941, designated Tol I and Tol II, respectively. Tol II was marginally more hydrophobic than Tol I. Later, Shirata et al. [38] improved the method for detection of toxins and characterised eight di¡erent toxins. The toxins 4 and 6 were identi¢ed as Tol I and Tol II, respectively. Tox 4 (or Tol I) was the main component of the toxin pool.
Murata and Magae [53] extracted also four di¡er-ent toxins from a P. tolaasii strain isolated from Pleurotus caps, whose biochemical properties were similar to the tolaasin forms described by Nutkins et al. [54] and Shirata et al. [38] . According to their retention time in the HPLC chromatogram, these were named Tox 1, Tox 2, Tox 3 and Tox 4. Tox 3 constitutes ca. 94% of the total amount of toxins, whereas Tox 1, Tox 2 and Tox 4 account for ca. 1, 3 and 2%, respectively. However, the potential to induce brown blotch of Tox 3 per weight unit (toxicity index) was about the same as that of the other toxins. This could mean that the ability to provoke browning does not depend on the toxin composition.
Structure of tolaasin
Tolaasin is a lipodepsipeptide consisting of 18 amino acid residues, mainly D-isomers and some Lisomers. Two amino acids are unusual, it concerns homoserine (Hse) and 2,4-diaminobutyric acid (Dab). The molecule contains also two dehydroaminobutyric acid residues (vbut), a L-hydroxyoctanoic acid group at the N-terminus and it is cyclised via a lactone linkage at the C-terminus [54] . The primary structure of the main form (Tol I) is ( Fig. 2) :
Tol II is simply an analogue of Tol I in which the homoserine residue has been replaced by glycine. The rest of the tolaasin forms di¡er probably in other residues.
Circular dichroism studies indicate that the tolaa- sin con¢guration allows for favourable steric interactions to extend a left-handed K-helix conformation. The sequence contains hydrophilic and hydrophobic amino acids positioned in a speci¢c arrangement giving the formed K-helix an amphipathic character [55] .
Biosynthesis of tolaasin
Tolaasin is synthesised by a non-ribosomal mechanism requiring a multienzyme complex and perhaps also post-translational modi¢cations. The biosynthesis may proceed by formation of linear peptidyl intermediates further modi¢ed into speci¢c cyclic structures. The variable amino acid composition may be the result of the low speci¢city when the multienzyme complex is adding amino acid residues to the structure.
A gene cluster of 65 kb was identi¢ed in the bacterial genome at one end of a 640-kb PacI chromosomal fragment [56] , which was required for the biosynthesis of tolaasin. This chromosomal region encodes three high-molecular mass proteins (TL1 of 465 kDa, TL2 of 440 kDa and TL3 of 435 kDa) which were essential for the biosynthesis. When mutated, the production of the functional toxin was directly a¡ected. They may concern peptide synthetases.
Two other chromosomal loci essential for tolaasin synthesis were also identi¢ed, but their gene products are still unknown. One of these genes is located within the TL-cluster between the regions encoding TL1 and TL2 and the other gene is located outside the TL-cluster on PacI fragment B [56] .
TL1 is located in the membrane within the P. tolaasii cell envelope. The cellular location for TL2 and TL3 remains undetermined, but they are likely membrane-bound, forming a complex with TL1. Such an association would facilitate the combined synthesis and export out of the cell of the mature toxins.
Regulation of biosynthesis
The synthesis of tolaasin might be under control of a very strict regulatory system. Recent studies [57] pointed out the existence of extra-genomic DNA which mediates both toxin production and e¤ciency. The absence of this factor reduced pathogenicity but did not suppress it completely. The bacterium that lost the factor produced lower amounts or less e¤-cient toxin than the factor containing wild-type. The DNA sequence of this factor, possibly a plasmid, is being investigated.
Biological properties of tolaasin
Treatment of mushroom caps with tolaasin results in pitting and browning. Application of 10 Wg ml 31 caused pitting [58] and 30 Wg ml 31 of tolaasin caused browning and pitting after 16 h [59] . These macroscopical e¡ects result from a direct action of tolaasin on hyphal membranes.
Experiments using liposomes and observations by electron microscopy provided evidence that plasma membranes constitute the major cellular target of tolaasin. Tolaasin was able to provoke haemolysis on horse erythrocytes. Its activity was dependent upon the erythrocyte concentration which suggested that lysis was dependent upon the rate at which tolaasin molecules insert into and/or aggregate within membranes. The temperature, pH and bu¡er composition a¡ected the rate of tolaasin-induced haemolysis. Divalent metal ions (Zn 2 ) inhibited the e¡ect, pointing out that haemolysis resulted from the formation of pores in the erythrocyte plasma membrane. Using osmotic protectors, the pore size was determined as 0.6^10 nm (radius). Tolaasin molecules were unable to dissociate from the membrane once inserted [39] .
The addition of 0.3 WM tolaasin to planar lipid bilayers resulted in movement of ions across the membrane, demonstrating the ability of tolaasin to form ion channels. A single tolaasin molecule could not be responsible for the formation of a ion channel across the membrane because of its small size, so probably, channels are constituted by aggregation of amphipathic K-helical molecules. The ion channels showed to be strongly cation selective. Zn 2 was able to inactivate them, probably via chelation of ionisable groups in the membrane near the site of pore formation [59] .
The inability of an altered toxin (which lacks three amino acids from the K-helical region of the molecule [60] ) to form ion channels in lipid bilayers and to cause erythrocyte haemolysis at wild-type e¡ective tolaasin concentrations further indicates that ion channel formation is the mechanism of haemolysis [39] . The pores formed in the membrane were in fact ion channels.
The amphipathic character of tolaasin and observations on its critical mycelial concentration pointed out that tolaasin had also biosurfactant properties [58] . The detergent activities were not a¡ected by the presence of Zn 2 , suggesting that tolaasin lyses erythrocytes by two mechanisms. The ¢rst one may occur at low concentrations of tolaasin and is the result of ion channel formation (Zn 2 -sensitive). The second may occur at high concentrations and result from a biosurfactant action (Zn 2 -insensitive). Perhaps in vivo, the two mechanisms are involved but until now, the precise tolaasin concentrations at the mushroom caps are di¤cult to evaluate [58] .
Apart from the major target of the toxin, the disruption of plasma and vacuole membranes rending the collapse of mushroom cells, other roles have been described. The toxin inhibits the growth of almost all fungal cultures and Gram-positive bacteria and causes cytolysis and necrosis in various plants [39] .
It is also involved in the spreading of the colonies and the disease, acting as surfactant on the water condensed on mushroom caps [58] .
Other agents
Tolaasin and the extracellular enzymes mentioned above are not the only compounds responsible for bacterial botch symptoms. Park et al. [61] isolated a new compound from a P. tolaasii strain, inducing the symptoms of the disease on A. bisporus caps. After puri¢cation, this compound was characterised as an aminobenzene containing an amylamine group.
More recently, Shirata et al. [62] described volatile compounds produced by the bacterium that are also part of the infection process. These compounds, called tovsins, were di¡erent from tolaasin and able to induce browning and rotting on P. ostreatus and F. velutipes on both cultivating and packed fruitbodies. Fig. 3 .`White line test' according to Wong and Preece [66] . Drops of various unidenti¢ed bacteria were streaked at both sides of two lines of P. reactans. Colonies that showed a white precipitate in between the two bacteria, after 2 days of incubation at 24³C on King's B medium [23] , were pathogenic strains of P. tolaasii.
Experimental assays for identi¢cation of the pathogenic bacterium
Gandy [63] designed a rapid method to screen for pathogenic bacteria and to compare the intensities of damage. Caps of fresh sporophores were harvested and cut in blocks with the outer tissue peeled o¡. One drop of bacterial suspension was applied on the blocks. A rapid pitting of the mushroom blocks was observed within 10 min after a drop suspension was placed, long before browning. This e¡ect was observed when the blocks were inoculated with P. tolaasii and other strains, such as Arthrobacter, which also cause brown blotch [64] . Therefore, this test was ideally suited for screening brown blotch pathogens in general, but, when a more detailed study is required, the test should be performed using whole caps. Cap surface (pileus) was described as an important factor to improve the selectivity of the test when comparing the expression of symptoms [65] .
Wong and Preece [66] designed a reliable test based on the speci¢c in vitro interaction that was observed between pathogenic forms of P. tolaasii and a mushroom saprophytic bacterium called Pseudomonas reactans. When these two types of bacteria were streaked several mm apart onto King's B medium [23] and incubated at 25³C for 48 h, a white precipitate could be observed, as a line in between the colonies (Fig. 3) . This`white line test' was highly speci¢c to pathogenic P. tolaasii and constitutes a simple and reliable test for its identi¢cation.
The precise reaction mechanism occurring in the formation of the white precipitate is still unknown. The white line results from a speci¢c interaction between a di¡usible compound produced by P. reactans (called the white line inducing principle, WLIP) and tolaasin.
WLIP is a lipodepsipeptide with a molecular mass of 1125 Da and presents structural similarities to tolaasin such as a lactone at the C-terminal region, a peptidic chain in the central region and a L-hydroxydecanoic acid group at the N-terminal region [67] (Fig. 4) . WLIP di¡ers from tolaasin because its molecule is folded as a L-turn type II [68] .
The host: A. bisporus
Colonisation of A. bisporus caps by P. tolaasii results in brown discolouration, appearing as brown dots on the damaged area. During senescence, developing fruitbodies also turn homogeneously brown. This browning is caused mainly by the oxidation of phenolic substances, which are catalysed by polyphenol oxidases (PPO). In A. bisporus sporophores, PPOs are mainly tyrosinases [69] while laccases are mostly located in the mycelium [70] . Tyrosinases were present throughout the entire fruitbody, but the gills, stalk and epidermis were more abundant [71] .
Tyrosinase
Tyrosinase (EC 1.14.18.1) catalyses the ortho-hydroxylation of monophenols (cresolase activity) and the oxidation of ortho-diphenols into ortho-diquinones (catecholase activity) (Fig. 5) . The physiological meaning of tyrosinase in mushrooms is still unclear.
Several authors proposed tyrosinase as participant in the biosynthetic pathway of 2-hydroxy-4-iminoquinone [72] but most of them attributed a role in the defence mechanism because of the properties of its products. o-Quinones can link proteins and inactivate them or polymerise into melanins. o-Quinones and melanins have a large bacteriostatic power. On the other hand, tyrosinases might also be involved in spore formation and stability [73] .
Characterisation of the tyrosinase structure
A. bisporus tyrosinase is one of the most extensively investigated PPOs, but our knowledge about the enzyme remains incomplete and sometimes even appears to be contradictory. Puri¢cation of the enzyme is a hard task. According to the method used, results may vary. As a consequence, multiple forms of mushroom tyrosinase have been reported.
The multiplicity appeared to be based on the existence of several isozymes that can exist in various states of aggregation, ranging from monomer to octamer or higher. Transformation from one polymer to another is described as an equilibrium where the tetrameric association is the most predominating form [74, 75] .
SDS electrophoresis analysis showed that tyrosinase was composed of two types of polypeptide chains, a heavy chain of 43 kDa and a light chain of 13.4 kDa. The isolated H and L subunits did not present any activity by themselves and need to be associated as an active heterotetramer H 2 L 2 with a molecular mass of 120 kDa [76] . Later, a new organisation of the quaternary structure was proposed by Robb and Gutteridge [77] , who identi¢ed two types of heavy chains with a 3-kDa di¡erence. These were called H K and H L . The proposed structure was then H K 2 L 2 , which corresponded with isoenzyme K and H L 2 L 2 , which could be isoenzyme Q. Recently, two monomeric tyrosinase isoforms were isolated from the fruitbodies, possessing both catecholase and cresolase activity [78] . Both isoenzymes exhibited a molecular mass of 43 kDa under denaturing conditions and 47 kDa under native conditions, suggesting that both isoforms occur as monomeric single chain polypeptides. The isoforms were distinguished by their pI values of 5.2 and 5.1.
Studies at the DNA level
Two full length cDNA fragments of 1.9 (AbPPO1) and 1.8 kb (AbPPO2) were isolated from a cDNA library of A. bisporus. Both sequences presented signi¢cant homology to Neurospora crassa pro-tyrosinase (34%) and no homology to A. bisporus laccases (lcc1 and lcc2) [79] . AbPPO1 and AbPPO2 showed 43% homology (nucleotide level).
The open reading frame of both sequences encodes a protein of ca. 64 kDa. The latter could represent a pro-tyrosinase further processed by post-translational modi¢cations into the 43-kDa protein (a similar mechanism was described in N. crassa where a 75-kDa protein was processed into a 46-kDa mature form [77, 80] ). The mature enzyme might have a ten- dency to associate, forming dimers or tetramers of 120 kDa etc.
Latent and active forms
Tyrosinases from various organisms are normally synthesised in a latent form that is activated upon arrival to the destinatory organelle, normally through cleavage of a peptide by speci¢c proteases. Mushroom tyrosinases are supposed to exist in the cytosol of the cells or lightly bounded to organelles. They occur for almost 99% in an inactivated form [69] . Commercial mushrooms are white, so probably, tyrosinase is kept latent as the result of a very strict regulation and separation from its substrates by subcellular compartmentalisation [81] . However, whenever cells are broken, such as by bruising, senescence, extreme environmental conditions, maturation or infection, the cellular contents break out and mix with each other. Phenols are liberated to the cytoplasm while oxygen penetrates in the intercellular environment and the enzyme becomes activated initiating the enzymatic oxidation almost spontaneously. This cascade ends in the synthesis of brown melanins [73] .
Phenolic substrates and melanins
In A. bisporus, two monophenols are the main precursors of melanin: L-tyrosine and Q-glutaminyl-4-hydroxybenzene (GHB), both derived from the shikimate pathway [82] . In the presence of tyrosinase, they are oxidised into their corresponding o-diphenols (3,4-dihydroxyphenylalanine (L-DOPA) and Qglutaminyl-3,4-dihydroxybenzene (GDHB), respectively). These compounds are also substrates of the enzyme and oxidised into their corresponding o-quinones (dopaquinone and GBQ, respectively). The latter are extremely unstable and rapidly polymerise to form DOPA-melanins and GHB-melanins (Fig.  6) . A. bisporus melanins are heterogeneous molecules with a wide range of colouration from yellow to black including red and purple. They are mainly composed of GHB derivatives subunits [73] .
The biological role of GHB in mushrooms is still unclear. Melanins represent a defence system in all organisms as well as a resistance mechanism to stress. In fungi, melanins also appear to be important in conferring resistance to microbial attacks [83] . They can also have an antibiotic e¡ect against antagonist organisms. The main role of fungal melanins is probably to provide protection against hydrolytic enzymes, such as glucanases and chitinases, thus preventing cell wall lysis [84] .
Interaction host-pathogen
P. tolaasii is a bacterium endemic of the compost and the casing soil. It is part of the £ora associated with mushroom hyphae. Detailed studies on several composts used in various farms discover the pathogen [85] present in the compost before and after peak heating, during spawning and during cropping. The pathogen was also observed in the peat and the limestone [50] . Therefore, compost and casing soil required for mushroom cultivation were found as a primary source of the disease. Once the pathogen is in the farm, the disease can be spread through the pests and the picker hands transferring the bacterium from one house to another [86] .
In compost, £uorescent Pseudomonas strains are very common. They constitute 10% of the total aerobic population that was calculated as 10 7^1 0 8 bacteria g 31 compost. Casing soils contain usually less bacteria than compost (approximately 6U10 6 bacteria g 31 ) but migration of P. tolaasii from compost into the casing soil was also reported [87] .
Threshold concentration for the development of the disease
Arti¢cial inoculations were performed in casing layers on commercial mushroom beds to investigate the bacterial concentrations and the symptom development in controlled environments. Very low P. tolaasii concentrations (20 cfu cm 32 ) present in a casing surface can provoke severe epidemics of brown blotch disease, as the bacterium is able to grow on the fungal mycelium and on developing mushrooms. But the minimal number of cells able to produce brown lesions 48 h after the bacterial suspensions were placed on mushroom caps is di¤cult to estimate because of the instability of the bacterium. Different concentrations were reported as threshold values, the proposed values ranging from 6U10 7 [88] The threshold value was found irrespective of the size or age of mushroom primordium or cap. The disease may be visible in crops at a very early stage or symptomless, although the pathogen is present [88] .
Colonisation of A. bisporus hyphae
Typically, the P. tolaasii cell has one or more £ag-ella at one or both of its poles used for locomotion. P. tolaasii has special £agella types whose composition was shown to be di¡erent from most of the rest of Pseudomonas £agellae [92] . The nutrient-poor but water-soaked casing layer close to A. bisporus hyphae provides a nutrient gradient which stimulates and facilitates bacterial migration [87] . P. tolaasii can modify its position depending on`signals' produced by the mushroom, being chemotactically attracted towards it. The nature of the attractants is still unknown. The rough variant showed a more rapid chemotactic response than the smooth wildtype form [93] .
Once the bacteria migrate towards the detected nutrient source such as A. bisporus mycelium and reach the surface of the hyphae, they should attach to the mycelium. Wild-type P. tolaasii was found consistently attached to the mycelium and in greater numbers than the phenotypic variant [94] . Between 99.3^84% of the cells were strongly attached immediately after inoculation [88] . 10 min later, 74% of the smooth cells remained attached while only a few cells of the phenotypic variant of P. tolaasii were still seen attached. Therefore, both the attachment and the chemotactic processes di¡ered markedly between pathogens and non-pathogens [95] .
Observation of the £ora associated with hyphae by scanning electron microscopy (SEM) revealed rods, vibrio-like rods and cocci [96] . Some bacteria were attached to hyphae and to each other by ¢lament-like structures which were morphologically di¡erent from £agella, ¢mbriae or pili [97] .
These attached bacteria were observed more often on young hyphae than on old ones [98] . Possibly, the exuded metabolites attract chemotactically the bacteria towards the young hyphal surface [93] . The attached bacteria (mostly P. £uorescens, P. putida) could easily be distinguished from P. tolaasii cells. P. tolaasii cells have a smooth surface and very clear £agella and the saprophytic bacteria showed a rougher surface [97] .
Transverse sections from the exterior hyphae of infected caps studied by transmission electron microscopy showed that, at initial stages of infection, the calcium salt crystals that normally surround the hyphae are replaced by bacteria ¢xed to the hyphal surface by a large amount of amorphous material [94] . According to TCH staining (Thiëry reaction), this material, secreted by the bacteria, appeared to be polysaccharides [25, 99] .
In a later infection stage, P. tolaasii provokes breakdown of the intercellular matrix between the mushroom hyphae, reduction of the central vacuole and all membrane systems become visibly broken within partially collapsed cells [100] . The plasmalemma becomes disrupted, organelles disorganised and the hyphal wall appears to thicken [101] .
In an advanced stage of the infection, a dark staining material accumulates at hyphae from the cap surface. Hyphae walls become thicker and ¢lled with a homogeneous electron dense, dark staining and granular material (indicating the presence of lipids and proteins) forming a layer of lightly packed walls with only remnants of degenerate cytoplasm. These formations appear to form a barrier excluding the pathogen from the internal hyphae, perhaps as a resistance mechanism operating in the fungus [100] .
Damage caused by P. tolaasii was seen extended into mushroom cap hyphae to a signi¢cant depth, not only on surface hyphae but penetrating more deeply. Tolaasin may be responsible for this intracellular damage since collapsed hyphae are observed Fig. 6 . Biosynthesis of melanins in A. bisporus, that originates in the shikimate pathway derived from the Krebs cycle. Conversions catalysed by tyrosinase that occurred initiating the chain of reactions producing DOPA-melanins and GHB-melanins [73] are indicated (7) and (D).
in areas where the bacteria could not reach. These hyphae were surely a¥icted by its toxin [100] .
Mushroom response to the infection

Resistance within the strains
A wide diversity of A. bisporus strains is actually commercialised, showing a di¡erent appearance in size, texture, colour, etc. Wild-type collections, amongst other from forests, o¡er a vast genetic variability which holds promise for identifying resistance to P. tolaasii infection [102] .
The e¡ect of the brown blotch disease has been studied, therefore, on a large range of strains (commercial hybrids and wild-types), in a search for resistant strains. Di¡erences in susceptibility among spawns and fruitbodies of A. bisporus strains have been widely reported [52, 103] , brown mushrooms were always found more resistant than white strains [65] , but none of them was completely resistant.
Moquet et al. [104] infected a very large collection of hybrid and wild A. bisporus strains with two P. tolaasii strains and their toxins. A great diversity in symptom intensity was observed among the strains. Unfortunately, none of the 115 strains investigated was absolutely resistant to the bacterium or to the toxin concentration applied. Nutkins et al. [54] reported that partially puri¢ed toxin reproduces disease symptoms as does the intact organism. According to the ¢ndings of Moquet et al. [104] , the responses of various A. bisporus strains to these inoculum types were not exactly the same. The toxin induced more prominent symptoms than living bacteria did. Symptoms after bacteria or toxin inoculation have the same visual aspect (brown, sunken), but when a wide set of A. bisporus strains is considered, some di¡erences occurred in symptom intensity.
A method to assess mushroom blotch resistance was developed by Olivier et al. [90] and derived studies indicated that cap resistance increased with £ush numbers, regardless of A. bisporus and P. tolaasii strains ( Table 1) . Development of lesions did not depend on the morphological stage of the mushroom at which it was inoculated.
Studies on di¡erent progenies, quantitative trait loci (QTL) could explain the low susceptibility of certain strains. The main QTL was found as linked to the allele controlling the brown colour [105] , but not linked to tyrosinase encoding loci. That could be related to the behaviour of brown strains previously mentioned in the literature [65] . The di¡erences in the susceptibility of white strains are still unexplained from a genetic point of view, delaying the introduction of a white resistant strain on the market. In the same work, it was also observed that the expression of the resistance/susceptibility is highly dependent on environmental factors, as compost quality [105] , the reaction of the mushroom being in£uenced by nutrients.
Defence mechanisms against bacteria
The most economically important cultivated fungi have been shown to degrade living bacterial cells. For instance, L. edodes and Lentinula tigrinus revealed bacteriolytic abilities [106] . Their hyphal tips were able to degrade P. £uorescens and P. tolaasii through production of lytic enzymes. P. ostreatus is also well known able to attack and degrade living bacterial cells on low-nutrient agar and on wood [107] .
A. bisporus also produces extracellular bacteriolytic and fungolytic enzymes. It can use heat-killed bacterial cells of Bacillus subtilis as main nutrient source [108] and it is able to use other fungi and actinomycetes as a sole source of carbon, nitrogen and phosphorus, providing up to 10% of the A. bisporus nutritional requirements for its cropping cycle [109, 110] . Decomposition of bacteria by various ¢lamentous fungi takes place by cytolysis and bacteriolysis using either speci¢c carbohydrases or speci¢c peptidases [111] . Two main bacteriolytic enzymes have been reported in A. bisporus strains, a L-N-acetylmuramidase [112] and a L-N-acetylglucosaminidases (carbohydrases) [110] . Other heat-labile antimicrobial compounds produced by A. bisporus mycelium have been described against bacteria [113] , but until now, nothing has been described about bacteriolysis of P. tolaasii. Only a few indications of a possible defence mechanism were suggested by SEM illustrations where a homogeneous electron dense material appeared as a barrier between the pathogen and internal hyphae [95] . Light micrographs of A. bisporus hyphae infected by Verticilium showed a layer of brown deposited pigments in the area close to the pathogen as well [114] . These brown pigments could be toxic compounds, such as melanins, produced by A. bisporus in order to inhibit the pathogen growth [14, 83, 107, 115] .
Infection at a molecular level
The sequence of events occurring from P. tolaasii infection until the appearance of discolouration phenomena on the A. bisporus cap was recently investigated at the molecular level. The studies provided a more precise understanding of the mechanism of infection and a clearer view to further control the disease.
E¡ect on mushroom tyrosinases
Three A. bisporus strains with a di¡erent resistance towards bacterial blotch were infected with P. tolaasii or treated with a tolaasin extract. In the two more susceptible strains, the total tyrosinase level (latent and active forms) decreased upon treatment with bacteria or the toxin containing extract. The amount of active tyrosinase increased, suggesting an activation of tyrosinase upon infection or treatment. In the more resistant strain, the tyrosinase activity remained unchanged [116] .
In one of the A. bisporus strains (with intermediate susceptibility), discolouration due to senescence was compared with the blotch-related discolouration and was found di¡erent. Browning provoked by the bacterium was not a strongly accelerated version of the senescence process but followed a di¡erent mechanism to form melanin. In infected mushrooms, degradation of total tyrosinase and activation until approximately 6% of the total tyrosinase [117] was observed while in senescing mushrooms, no activation and low degradation of the enzyme was detected (Fig. 7) . When tyrosinases from infected and healthy mushrooms were visualised after SDS-PAGE, West- ern blotting and staining with polyclonal tyrosinase speci¢c antibodies, a main band at 67 kDa that might correspond to the latent form was revealed. Another band at 43 kDa, whose intensity increased in mushrooms treated with the toxin, was also observed, which might represent an active tyrosinase isoform [78, 89] .
Tolaasin by itself was able to provoke browning and activation of tyrosinase. The activation level of tyrosinase was related to the concentration of toxin applied. In healthy mushrooms, the main active tyrosinase isoforms exhibited a pI of 4.5 and 4.4 [118] . Tolaasin treatment resulted in activation of a pI 5.7 tyrosinase isoform. Active isoforms showed also different kinetic parameters. For instance, a tolaasinactivated isoform had a higher a¤nity for catechol as substrate than tyrosinases from healthy mushrooms [89] .
The activation of tyrosinase seemed to be a rather speci¢c response towards P. tolaasii. Arti¢cial inoculation of mushrooms with other pathogens (P. agarici, P. gingeri, Verticillium fungicola or Trichoderma harzianum) resulted in degradation of total tyrosinase to a di¡erent extent possibly due to proteolytic secretions. Only infections with P. tolaasii (until almost 7%) and V. fungicola (less than 3%) induced activation of tyrosinase [89] .
The e¡ect of the infection at the molecular level was not only the activation of tyrosinase. Tolaasin was also able to induce transcription of mRNA encoding tyrosinase (AbPPO2). The induction was speci¢c for one of the genes because no e¡ect on AbP-PO1 expression was observed following inoculation with the bacterium or treatment with a partially puri¢ed or pure tolaasin preparation [89] .
E¡ect on the phenolic substrates and melanin
concentrations When A. bisporus was infected with P. tolaasii suspensions or treated with toxin preparations, phenolic substrates of the active tyrosinase were oxidised proportionally to the damage detectable on the mushroom cap. GDHB levels were decreasing ¢rstly, followed by GHB and later tyrosine levels. The amount of melanin that was synthesised during the infection was larger than the sum of oxidation of the three mentioned phenols, indicating the existence of an other in£ux of phenolic compounds from other metabolic processes to form melanin (Fig. 8) [117] .
Principal component analysis, a multipurpose statistical software package, demonstrated that the amount of phenolic compounds present in an A. bisporus strain and the levels of active tyrosinase are the most important parameters to determine the susceptibility of that strain to the browning induced by the brown blotch disease [117] .
In£uence of the mushroom proteases
In basidiomycetes, there is clear evidence for the regulatory role of proteases in the senescence proc- esses. For instance, these are known to regulate the fruitbody formation of L. edodes [119] and are responsible for the fungal tissue autolysis contributing to a loss of sporophore texture and quality. During senescence of A. bisporus sporophores, proteinase activity is increasing [120, 121] provoking activation of enzymes such as chitin synthase [122] and tyrosinases, resulting in softening and browning of the fruitbodies [4] .
In regions of the sporophore that were infected with P. tolaasii, protease levels were found to increase, but not when mushrooms were treated with a toxin preparation, suggesting that the activation of tyrosinase in the latter case was not induced by bacterial proteases. This observation was con¢rmed with in vitro experiments in which tyrosinase was found to be activated by a protease-free tolaasin containing preparation [116] .
Molecular mechanism of infection
According to the investigations described in previous paragraphs, the sequence of events until the development of the symptoms could be hypothesised to comprise a number of steps. (1) The bacterial population locally increases in relation with environmental factors such as temperature or water availability (condensation). (2) P. tolaasii`senses' the mycelial hyphae and migrates towards it. When it reaches the mushroom cap, it excretes EPS and/or other materials to ¢x itself to the hyphal membrane. Then, it synthesises and excretes tolaasin, the toxin with surface active properties able to provoke membrane disruption, to obtain nutrients from the inside of the mushroom cells. (3) Tolaasin breaks membranes and decompartmentalisation and cell disorganisation occur. (4) Mushroom proteases that may be con¢ned (perhaps in an inactive form) inside organelles are liberated to the cytoplasm where they become activated. (5) Proteases activate the latent tyrosinase, probably by cutting a peptide that is covering the active site. (6) Active tyrosinase in contact with its substrates (present in the cytoplasm or inside organelles that were disrupted by tolaasin) catalyses their oxidation into melanins. (7) Melanins and quinones are complex molecules that disturb the normal development of the bacterium, thereby producing a chemical barrier against the infection of other cells.
Concomitantly, other parallel reactions may occur. (I) P. tolaasii produces proteases and lipases. Bacterial proteases could also in£uence the activation of mushroom tyrosinase and lipases facilitate membrane breakdown. (II) Tolaasin may also directly activate tyrosinase because of its surface active properties, as well as proteases and detergents are able to activate tyrosinases [123, 124] . (III) P. tolaasii possibly also produces RNAses during the infection, which contribute to the disorganisation of the cells by preventing synthesis of proteins. RNA present in bacterium-infected samples was always found almost completely degraded [89] . However, even in this stressed situation, transcription of tyrosinase (AbP-PO2-mRNA) still occurs.
According to the complex mechanism described above (1^7 and I^III), the activation of tyrosinase could be considered only as a result of the cell disorganisation. In such a case, however, no induction of AbPPO2-mRNA should have occurred. These observations indicate the levels of this enzyme to be kept constant or increasing in a case of infection, supporting the hypothesis that tyrosinase could be involved in the defence mechanism of the mushroom. Particularly interesting is the observation that only one of the two isoenzymes is transcribed. Further research in this matter might lead to further interesting insight in the physiological role of the enzyme. Considering all these hypotheses about the sequence of reactions and side-reactions that may occur during the infection, the more adequate target to stop the sequence of events should be tolaasin.
Control
Many investigations have been carried out to ¢nd an adequate method to prevent or control the disease. Manipulation of the environmental conditions (precise relative humidity (r.h.) and temperature, adequate ventilation system, disinfection of the walls and soils, etc.) plays an essential role to minimise the possibility of an epidemic, however, with no guarantee for success [2, 65, 125, 126] . Calcium chloride and chlorinated compounds are, at the present, the most commonly utilised chemicals for brown blotch disease control [127^129]. However, many secondary e¡ects remain associated with their use, so several other chemicals, disinfectants and antibiotics have been studied for their ability to control bacterial blotch. So far, none has been found fully e¡ective and non-toxic to humans [21,130^134] . Also, biological control with antagonistic microorganisms and/or speci¢c phages has been investigated [19,91,135^139] . Competing bacteria were not always found to prevent incidence and currently, strains of P. tolaasii naturally resistant to the phage have already been discovered [140, 141] .
Recent studies proposed WLIP, the lipodepsipeptide of P. reactans [142, 143] , as a potential inhibitor of the symptoms of the brown blotch disease of A. bisporus. Applications of WLIP on mushroom caps before inoculation (with bacterial concentrations higher than the threshold) protected the mushroom against the bacterium and they did not show discolouration. The inhibition of the browning was also e¡ective when incubating at low temperatures and during 4 days, but its e¤ciency at a commercial scale has not been tested yet [89] .
Nowadays, other procedures for control are being developed, such as selection and production of resistant strains. Crossing A. bisporus with other Agaricales was not possible because of the special life cycle of the cultivated mushroom. Since the recent discovery of A. bisporus var. burnettii, a heterothallic and tetrasporic variety [144] , crosses become possible. Some other advances have been made in the production of A. bisporus hybrids. So far, only brown strains showed a certain degree of resistance, the white varieties still being highly susceptible. However, the strains of high interest for growers are those with a low susceptibility and white colour. Obtaining such a variety is still a highly time-consuming task [2] .
Advances in molecular biology and techniques for the production of transgenic mushrooms could contribute to the solution by`creating' a disease resistant A. bisporus [145, 146] . Recently, transformation systems for A. bisporus were developed [147^149]. Transforming DNA was integrated into the A. bisporus genome and expressed. Many A. bisporus gene libraries have been constructed but no speci¢c gene has been identi¢ed as responsible for the immunity to the disease [146] . In fact, resistance or susceptibility seems to be controlled by di¡erent sets of genes [105] . Therefore, a better knowledge of the mechanisms involved in the interaction bacteria-mushroom is required to identify those`key genes' or`target genes' to be modi¢ed among the di¡erent libraries. A ¢rst attempt on modi¢cation of those`target genes' could be the silencing of mushroom tyrosinases. The AbPPO1 and AbPPO2 sequences were isolated by PCR [79] and used to prepare antisense and gene disruption constructs, which resulted in the generation of 167 putative transformants [150] . The homokaryotic transformants must be mated with a compatible non-transformed strain to obtain fertile heterokaryons. However, it is uncertain whether the production of fruitbodies with only one transformed nucleus will silence the expression of the target gene. It is also uncertain whether in case of infection with P. tolaasii, transformed mushrooms will show the symptoms of the disease. As yet, no reliable transformation method of the two homokaryotic compatible mycelia has been developed.
Transformation on P. tolaasii has also been studied to use the same microorganism as antagonist. Treatment of the crop with a transgenic P. tolaasii that is identical to the pathogen but unable of tolaasin production could provide the best competition. At present, a transformation system for P. tolaasii by electroporation has been successfully developed but its e¤ciency as antagonist against the natural strain is still not tested [151] .
Conclusion
Currently, brown blotch disease of A. bisporus is still an important problem for the growers. P. tolaasii is not an easy bacterium to eliminate because it can modify its biochemical pathways to survive in many adverse environments. This capacity allows the bacterium also to compete and obtain nutrients over its competitors. Some antagonist microorganisms have been described as able to interfere in the development of the disease but not enough to solve the problem for the growers. Still, chemical additions are the most generally used control method causing unexpected and uncontrolled discolourations.
Considering the hypothesis about the sequence of reactions and side-reactions, described in this paper, that may occur during the infection, the more adequate target to stop the sequence of events should be tolaasin. The fact that WLIP is able to inhibit the browning could con¢rm this hypothesis. The mechanism in the`white line test' whereby the white line is formed is not well understood but, perhaps, in vivo, WLIP can also scavenge tolaasin, disabling the toxin to provoke membrane disruption. The special structure of the toxin and the K-helix con¢guration have been probed important tools for its ion channel forming and surface active properties. Further research into the use of WLIP, perhaps in combination with other compounds, e.g. lysozyme [89] , awaits research. The possibility to apply it during growth and a thorough feasibility study that should include the anticipated cost of production, balanced against expected economic bene¢ts and legislative aspects should be evaluated.
Investigation of other compounds with a structure similar to WLIP, such as, i.e., viscosin [152] produced by Pseudomonas viscosa, that di¡er from WLIP only in the spatial con¢guration of one of its amino acids, or other lipodepsipeptides [1531 56] could also open interesting perspectives. The surest way to control the disease might be the combination of di¡erent methods (biological, biochemical, genetic, etc.). The incidence of the brown blotch disease would be minimised by (1) using a low susceptible A. bisporus strain, (2) an adequate substrate for culture with a low content of pathogens, (3) a system to control the environmental conditions and (4) additions of compounds as WLIP to protect the crop in case of a very virulent P. tolaasii strain.
